Related references
Note: Only part of the references are listed.MR elastography of the head and neck: Driver design and initial results
David K. W. Yeung et al.
MAGNETIC RESONANCE IMAGING (2013)
Transperineal prostate MR elastography: Initial in vivo results
Ramin S. Sahebjavaher et al.
MAGNETIC RESONANCE IN MEDICINE (2013)
EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology
J. Bamber et al.
ULTRASCHALL IN DER MEDIZIN (2013)
False-negative MRI biomarkers of tumour response to targeted cancer therapeutics
J. K. R. Boult et al.
BRITISH JOURNAL OF CANCER (2012)
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
L. C. J. Baker et al.
BRITISH JOURNAL OF CANCER (2012)
Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development
Ralph Sinkus et al.
EUROPEAN JOURNAL OF CANCER (2012)
Qualification of imaging biomarkers for oncology drug development
John C. Waterton et al.
EUROPEAN JOURNAL OF CANCER (2012)
MR elastography of liver tumours: value of viscoelastic properties for tumour characterisation
Philippe Garteiser et al.
EUROPEAN RADIOLOGY (2012)
Colon Tumor Growth and Antivascular Treatment in Mice: Complementary Assessment with MR Elastography and Diffusion-weighted MR Imaging
Lauriane Juge et al.
RADIOLOGY (2012)
Tumor Microenvironment and Progression
Harold F. Dvorak et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Improving Apparent Diffusion Coefficient Estimates and Elucidating Tumor Heterogeneity Using Bayesian Adaptive Smoothing
Simon Waker-Samuel et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Guidelines for the welfare and use of animals in cancer research
P. Workman et al.
BRITISH JOURNAL OF CANCER (2010)
Diagnostic value of MR elastography in addition to contrast-enhanced MR imaging of the breast-initial clinical results
Katja C. Siegmann et al.
EUROPEAN RADIOLOGY (2010)
Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial
Dow-Mu Koh et al.
EUROPEAN RADIOLOGY (2009)
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
[Anonymous]
NEOPLASIA (2009)
MR elastography of breast lesions: Understanding the solid/liquid duality can improve the specificity of contrast-enhanced MR mammography
Ralph Sinkus et al.
MAGNETIC RESONANCE IN MEDICINE (2007)
Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies
Michael R. Horsman et al.
CANCER RESEARCH (2006)
Measuring response in a post-RECIST world: from black and white to shades of grey
LC Michaelis et al.
NATURE REVIEWS CANCER (2006)
Tumor overexpression of inducible nitric oxide synthase (NOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126
ER Cullis et al.
MICROVASCULAR RESEARCH (2006)
Tensional homeostasis and the malignant phenotype
MJ Paszek et al.
CANCER CELL (2005)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
ZD6126: A novel small molecule vascular targeting agent
DC Blakey et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
MR elastography of the breast:: preliminary clinical results
J Lorenzen et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2002)
High-resolution tensor MR elastography for breast tumour detection
R Sinkus et al.
PHYSICS IN MEDICINE AND BIOLOGY (2000)
Share Paper
